Status:
TERMINATED
Massage Therapy for Self-efficacy in LVAD Recipients
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot study evaluates the role of massage therapy to improve self-efficacy in patients with advanced heart failure who have recently received a left-ventricular assist device. In addition to usua...
Detailed Description
Patients with advanced heart failure who undergo left-ventricular assist device (LVAD) implantation may experience notable physical and/or emotional distress associated with this lifestyle-changing pr...
Eligibility Criteria
Inclusion
- capacitated, at least 18 years of age, received LVAD implant during last hospital admission
Exclusion
- incapacitated, non-English speaking, negative pressure isolation, unstable spine, very low serum platelets (\<10,000/uL), received massage in 30 days prior to enrollment
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04018508
Start Date
September 1 2021
End Date
March 15 2022
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010